Cargando…
Associations between short-term efficacy and clinical characteristics of infantile hemangioma treated by propranolol
Propranolol is the mainstay of treatment for infantile hemangiomas (IHs) benefited from its low complication in the present study. However, it has an uncertainty treating period with cumbersome methods which may be related to clinical features. This study sought to considered possible influences of...
Autores principales: | Wu, Changhua, Guo, Lei, Wang, Liang, Li, Jing, Wang, Changfeng, Song, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380816/ https://www.ncbi.nlm.nih.gov/pubmed/30732164 http://dx.doi.org/10.1097/MD.0000000000014346 |
Ejemplares similares
-
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta-analysis
por: Liu, Zhuang, et al.
Publicado: (2020) -
Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)